Moreover, clinical studies have indicated that abnormal high serum GM-CSF levels are strongly associated with elevated serum βhCG levels in progressive tumor cases of choriocarcinoma [70], suggesting a potential pathological role for higher levels of GM-CSF and βhCG in gestational trophoblastic diseases. This evidence concerns the gene CSF2 and choriocarcinoma.